24th Sep 2018 06:36
LONDON (Alliance News) - AstraZeneca PLC Chief Executive Officer Pascal Soriot has warned of widespread shortages of medicines if Britain fails to agree a customs deal with the EU, the Sunday Times reported.
The Anglo-Swedish pharmaceuticals giant, which makes drugs such as the cholesterol-lowering Crestor, has already increased its stocks in the UK by 20%.
However, with a complex supply chain that involves manufacturing components of medicines across Europe, any friction at the border could cause severe delays, Soriot said, according to the newspaper.
Related Shares:
Astrazeneca